Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Rommel

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Nature Chemical Biology|January 19, 2010
The p110 delta structure: mechanisms for selectivity and potency of new PI(3)K inhibitorsAlex Berndt, Simon Miller, Olusegun Williams, et al.
Nature Chemical Biology|February 16, 2010
The p110delta structure: mechanisms for selectivity and potency of new PI(3)K inhibitorsAlex Berndt, Simon Miller, Olusegun Williams, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2007
Tissue- and stimulus-dependent role of phosphatidylinositol 3-kinase isoforms for neutrophil recruitment induced by chemoattractants in vivoVanessa Pinho, Remo Castro Russo, Remo de Castro Russo, et al.
Nature Medicine|August 30, 2005
Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritisMontserrat Camps, Thomas Rückle, Hong Ji, et al.
The Journal of Biological Chemistry|January 1, 2013
Selective inhibition of phosphoinositide 3-kinase p110α preserves lymphocyte functionLomon So, Sung Su Yea, Jean S Oak, et al.
Molecular and Cellular Biology|January 14, 2009
Convergent functional genomics of oligodendrocyte differentiation identifies multiple autoinhibitory signaling circuitsRosanna Pescini Gobert, Lara Joubert, Marie-Laure Curchod, et al.
Blood|May 10, 2005
Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophilsAlison M Condliffe, Keith Davidson, Karen E Anderson, et al.
Journal of Medicinal Chemistry|June 23, 2006
Furan-2-ylmethylene thiazolidinediones as novel, potent, and selective inhibitors of phosphoinositide 3-kinase gammaVincent Pomel, Jasna Klicic, David Covini, et al.
Nature|February 28, 2012
The translational landscape of mTOR signalling steers cancer initiation and metastasisAndrew C Hsieh, Yi Liu, Merritt P Edlind, et al.
Science Signaling|September 11, 2008
Phosphoinositide 3-kinase p110beta activity: key role in metabolism and mammary gland cancer but not developmentElisa Ciraolo, Manuela Iezzi, Romina Marone, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Nature Chemical Biology|January 19, 2010
The p110 delta structure: mechanisms for selectivity and potency of new PI(3)K inhibitorsAlex Berndt, Simon Miller, Olusegun Williams, et al.
Nature Chemical Biology|February 16, 2010
The p110delta structure: mechanisms for selectivity and potency of new PI(3)K inhibitorsAlex Berndt, Simon Miller, Olusegun Williams, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2007
Tissue- and stimulus-dependent role of phosphatidylinositol 3-kinase isoforms for neutrophil recruitment induced by chemoattractants in vivoVanessa Pinho, Remo Castro Russo, Remo de Castro Russo, et al.
Nature Medicine|August 30, 2005
Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritisMontserrat Camps, Thomas Rückle, Hong Ji, et al.
The Journal of Biological Chemistry|January 1, 2013
Selective inhibition of phosphoinositide 3-kinase p110α preserves lymphocyte functionLomon So, Sung Su Yea, Jean S Oak, et al.
Molecular and Cellular Biology|January 14, 2009
Convergent functional genomics of oligodendrocyte differentiation identifies multiple autoinhibitory signaling circuitsRosanna Pescini Gobert, Lara Joubert, Marie-Laure Curchod, et al.
Blood|May 10, 2005
Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophilsAlison M Condliffe, Keith Davidson, Karen E Anderson, et al.
Journal of Medicinal Chemistry|June 23, 2006
Furan-2-ylmethylene thiazolidinediones as novel, potent, and selective inhibitors of phosphoinositide 3-kinase gammaVincent Pomel, Jasna Klicic, David Covini, et al.
Nature|February 28, 2012
The translational landscape of mTOR signalling steers cancer initiation and metastasisAndrew C Hsieh, Yi Liu, Merritt P Edlind, et al.
Science Signaling|September 11, 2008
Phosphoinositide 3-kinase p110beta activity: key role in metabolism and mammary gland cancer but not developmentElisa Ciraolo, Manuela Iezzi, Romina Marone, et al.
Pageof 6